Facilities
Home / Facilities
Facilities are separated by drug group to prevent cross-contamination, with production areas, an R&D laboratory and QC laboratories on a 72,000 m² site.
Production buildings
| Building | Use | Area (m²) |
|---|---|---|
| A | Office | 5,200 |
| B | Cafeteria | 2,400 |
| C | Non-penicillin | 9,620 |
| D | Hormone | 1,456 |
| F | Cephalosporin | 1,456 |
| G | Penicillin | 1,768 |
Building C
Non-penicillin products
Buildings F · G
Cephalosporin (F) and penicillin (G) in separate buildings to prevent cross-contamination.
Building D
Hormone products